Individuals with sickle cell disease exhibit cardiovascular manifestations and sudden death as the top causes of premature death. These factors, unfortunately, contribute to the plateauing of the average life expectancy of these patients (in the 4th decade) over the past two decades, yet another profound health disparity observed in African Americans (AAs). Despite expanded understanding of the defining features including systemic vaso-occlusive episodes and hemolysis, there is a paucity of information linking cardiac pathology to premature death. Using system biology approaches, we have generated highly novel information characterizing a previously unrecognized human sickle cardiomyopathy defined by myocardial fibrosis, diastolic dysfunction, prolonged repolarization, and inducible ventricular tachycardia (VT) in the ?humanized? sickle mouse model. These studies further demonstrated significant upregulation of circulating IL18 gene expression, an established inflammasome and pro-fibrotic mediator upregulated by free heme, in sickle cardiomyopathy. Additionally, exposure to IL-18 was a key factor in inducing VT in sickle mice. Preliminary data further link decreased expression and activity of cardiac potassium channels (KCND2/KCND3) in sickle mice, which can prolong repolarization, to acute increases in IL-18-mediated NADPH oxidase 4 (Nox4) expression, the latter a key source of reactive oxygenation species (ROS) and induction of cardiac apoptosis. We have further shown that chronic IL-18 inhibition reduces cardiac apoptosis, fibrosis and improves diastolic function in sickle mice coupled with reduced cardiac IL-18 receptor (IL-18R) and Nox4 expression. Finally, our genomic studies have identified novel polymorphisms (SNPs) associated with enhanced IL18 expression and prolonged corrected QT (QTc) interval, an established risk factor for VT. Thus, via three specific aims (SAs), this R01 will interrogate the mechanistic basis for the hypothesis that IL-18/IL- 18R/Nox4 signaling critically downregulates KCND2 and KCND3 function acutely and promotes myocardial fibrosis with sustained activation, exacerbating sickle cardiomyopathy and VT development. SA #1 will functionally validate heme-mediated IL18 promoter regulation including SNPs in a monocyte cell line. SA #2 will define how IL-18/IL-18R/Nox4 signaling acutely downregulates KCND2/KCND3 function leading to prolonged repolarization and chronically, results in cardiac apoptosis and fibrosis. SA #3 will define the therapeutic efficacy of strategies to prevent sickle cell-associated inducible VT. The knowledge gained from this R01 will directly translate into future clinical biomarker studies evaluating risk of sudden cardiac death highlighting those patients with a higher hemolytic burden, pathogenic IL18 SNPs, and circulating IL-18 levels with theoretically higher VT risk. Additionally, the data will test for effective and novel personalized therapies in a poorly recognized and fatal manifestation of sickle cell disease.

Public Health Relevance

While individuals with sickle cell disease exhibit sudden death as the top causes of premature death, it is unclear whether patients experience fatal cardiac arrhythmias that contribute to these outcomes. Our preliminary data, for the first time, reveals inducible ventricular tachycardia (a fatal rhythm disturbance) in preclinical sickle animal models. We propose to study and therapeutically target inflammatory mechanisms as major contributors to the development of abnormal cardiac electrical properties and fibrosis (scar), both factors promoting a heart environment vulnerable to fatal arrhythmias.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL136603-05
Application #
9897593
Study Section
Molecular and Cellular Hematology Study Section (MCH)
Program Officer
Tinsley, Emily
Project Start
2017-04-01
Project End
2022-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Rafikova, Olga; Srivastava, Anup; Desai, Ankit A et al. (2018) Recurrent inhibition of mitochondrial complex III induces chronic pulmonary vasoconstriction and glycolytic switch in the rat lung. Respir Res 19:69
Rafikova, Olga; Williams, Elissa R; McBride, Matthew L et al. (2018) Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension. Am J Respir Cell Mol Biol 59:334-345
Kurdyukov, Sergey; Eccles, Cody A; Desai, Ankit A et al. (2018) New cases of Glucose-6-Phosphate Dehydrogenase deficiency in Pulmonary Arterial Hypertension. PLoS One 13:e0203493
Duarte, Julio D; Kansal, Mayank; Desai, Ankit A et al. (2018) Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients. Pulm Circ 8:2045894018773049
Gross, Christine M; Kellner, Manuela; Wang, Ting et al. (2018) LPS-induced Acute Lung Injury Involves NF-?B-mediated Downregulation of SOX18. Am J Respir Cell Mol Biol 58:614-624
Casillas, Andrea L; Toth, Rachel K; Sainz, Alva G et al. (2018) Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents. Clin Cancer Res 24:169-180
Whitaker, Morgan E; Nair, Vineet; Sinari, Shripad et al. (2018) Diabetes Mellitus Associates with Increased Right Ventricular Afterload and Remodeling in Pulmonary Arterial Hypertension. Am J Med 131:702.e7-702.e13
Tang, Haiyang; Babicheva, Aleksandra; McDermott, Kimberly M et al. (2018) Endothelial HIF-2? contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition. Am J Physiol Lung Cell Mol Physiol 314:L256-L275
Wang, Ting; Gross, Christine; Desai, Ankit A et al. (2017) Endothelial cell signaling and ventilator-induced lung injury: molecular mechanisms, genomic analyses, and therapeutic targets. Am J Physiol Lung Cell Mol Physiol 312:L452-L476
Pan, Minglin; Han, Ying; Si, Rui et al. (2017) Hypoxia-induced pulmonary hypertension in type 2 diabetic mice. Pulm Circ 7:175-185

Showing the most recent 10 out of 16 publications